RxSight Shares Rally After Launch of Advanced Cataract Surgery Lens Technology
• 1 min read
RxSight's stock surged over 7% following the release of its enhanced Light Adjustable Lens+ for cataract surgery patients. The medical technology company showcased strong financial performance with 78% Q4 revenue growth and projected continued expansion through 2024.